|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
80 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Angiogenesis and bone repair |
Carano, Richard A.D |
2003 |
21 |
p. 980-989 10 p. |
artikel |
||
| 2 | Beyond annotation transfer by homology: novel protein-function prediction methods to assist drug discovery |
Ofran, Yanay |
2005 |
21 |
p. 1475-1482 8 p. |
artikel |
||
| 3 | Beyond classical meta-analysis: can inadequately reported studies be included? |
Robertson, Chris |
2004 |
21 |
p. 924-931 8 p. |
artikel |
||
| 4 | Biofinance: what does the future hold? |
Lawrence, Rebecca N |
2001 |
21 |
p. 1094-1097 4 p. |
artikel |
||
| 5 | Biotechnology discovery productivity: a note of caution |
Cavalla, David |
2003 |
21 |
p. 973-974 2 p. |
artikel |
||
| 6 | Blood hot in Boston |
Hunter, A.Christy |
2002 |
21 |
p. 1082-1084 3 p. |
artikel |
||
| 7 | Can smooth muscle represent a useful target for the treatment of rapid ejaculation? |
Abdel-Hamid, Ibrahim A. |
2005 |
21 |
p. 1459-1466 8 p. |
artikel |
||
| 8 | Cathepsin enzyme provides clue to SARS infection |
Ashraf, Haroon |
2005 |
21 |
p. 1409- 1 p. |
artikel |
||
| 9 | Combinatorial chemistry |
Edwards, Paul |
2003 |
21 |
p. 1004-1005 2 p. |
artikel |
||
| 10 | Combinatorial chemistry |
Edwards, Paul |
2002 |
21 |
p. 1108- 1 p. |
artikel |
||
| 11 | Controlled release technologies for drug delivery |
Brayden, David J |
2003 |
21 |
p. 976-978 3 p. |
artikel |
||
| 12 | Copycat viruses outwit the immune system |
Clough, Joanne |
2002 |
21 |
p. 1067-1068 2 p. |
artikel |
||
| 13 | Distribution and licensing of drug discovery tools – NIH perspectives |
Ferguson, Steven M. |
2002 |
21 |
p. 1102-1106 5 p. |
artikel |
||
| 14 | Do all paths lead to DARPP-32? |
Foubister, Vida |
2002 |
21 |
p. 1068-1070 3 p. |
artikel |
||
| 15 | Drug delivery |
Weidner, John |
2001 |
21 |
p. 1129-1130 2 p. |
artikel |
||
| 16 | Drug designers learn their ABC |
Ferber, Dan |
2003 |
21 |
p. 960-961 2 p. |
artikel |
||
| 17 | Enhancing transdermal drug transport with low-frequency ultrasound |
Ng, Ka-Yun |
2004 |
21 |
p. 913- 1 p. |
artikel |
||
| 18 | Erratum |
2002 |
21 |
p. 1079- 1 p. |
artikel |
|||
| 19 | Gene expression analysis enriched |
Kriete, Andres |
2004 |
21 |
p. 913-914 2 p. |
artikel |
||
| 20 | Gene patents: are they socially acceptable monopolies, essential for drug discovery? |
Williamson, Alan R. |
2001 |
21 |
p. 1092-1093 2 p. |
artikel |
||
| 21 | Hans Küpper discusses science and venture capital |
Küpper, Hans |
2004 |
21 |
p. 909-912 4 p. |
artikel |
||
| 22 | Harnessing chromium in the fight against diabetes |
Brown, Matt |
2003 |
21 |
p. 962-963 2 p. |
artikel |
||
| 23 | Hello Drug Discovery, I am from Insilico, take me to your President |
Smith, Dennis A |
2002 |
21 |
p. 1080-1081 2 p. |
artikel |
||
| 24 | High throughput P450 inhibition screens in early drug discovery |
Zlokarnik, Gregor |
2005 |
21 |
p. 1443-1450 8 p. |
artikel |
||
| 25 | Hunting for the real cancer genes |
Habeck, Martina |
2003 |
21 |
p. 959-960 2 p. |
artikel |
||
| 26 | Investigating Wnt signaling: a chemogenomic safari |
McMillan, Michael |
2005 |
21 |
p. 1467-1474 8 p. |
artikel |
||
| 27 | Investment decisions in pharmaceutical R&D projects |
Pandey, Mohan |
2003 |
21 |
p. 968-971 4 p. |
artikel |
||
| 28 | In vitro trans-monolayer permeability calculations: often forgotten assumptions |
Youdim, Kuresh A |
2003 |
21 |
p. 997-1003 7 p. |
artikel |
||
| 29 | Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development |
Whitebread, Steven |
2005 |
21 |
p. 1421-1433 13 p. |
artikel |
||
| 30 | Microarray applications: emerging technologies and perspectives |
Mathias, Gebauer |
2004 |
21 |
p. 915-917 3 p. |
artikel |
||
| 31 | Monitor – biology |
Spitzer, Eric |
2004 |
21 |
p. 941-943 3 p. |
artikel |
||
| 32 | Monitor – business |
Carey, Jayne |
2004 |
21 |
p. 943- 1 p. |
artikel |
||
| 33 | Monitor – chemistry |
Westwell, Andrew D. |
2004 |
21 |
p. 940-941 2 p. |
artikel |
||
| 34 | Monitor – chemistry |
Westwell, Andrew D. |
2005 |
21 |
p. 1483- 1 p. |
artikel |
||
| 35 | Monitor: molecules and profiles |
Barlocco, Daniela |
2002 |
21 |
p. 1107-1108 2 p. |
artikel |
||
| 36 | Monitor: molecules and profiles |
Walker, Michael A |
2001 |
21 |
p. 1127-1129 3 p. |
artikel |
||
| 37 | Monitor – people |
Carey, Jayne |
2004 |
21 |
p. 944- 1 p. |
artikel |
||
| 38 | Multiple Drug Resistant Bacteria |
Taylor, Peter W |
2003 |
21 |
p. 978-979 2 p. |
artikel |
||
| 39 | New rodent models gnawing at the black box of ALS |
Senior, Kathryn |
2002 |
21 |
p. 1070-1071 2 p. |
artikel |
||
| 40 | News in brief |
Brown, Matt |
2003 |
21 |
p. 963-966 4 p. |
artikel |
||
| 41 | News in brief |
Ashton, V |
2002 |
21 |
p. 1072-1074 3 p. |
artikel |
||
| 42 | News in brief |
Owens, Joanna |
2001 |
21 |
p. 1083-1087 5 p. |
artikel |
||
| 43 | New ways to treat bacterial infections |
Taylor, Peter W |
2002 |
21 |
p. 1086-1091 6 p. |
artikel |
||
| 44 | Novel alternative for osteoarthritis |
Senior, Kathryn |
2005 |
21 |
p. 1409-1410 2 p. |
artikel |
||
| 45 | Patent opportunities in bioinformatics |
Rzucidlo, Eugene C |
2002 |
21 |
p. 1081-1082 2 p. |
artikel |
||
| 46 | PEGylation, successful approach to drug delivery |
Veronese, Francesco M. |
2005 |
21 |
p. 1451-1458 8 p. |
artikel |
||
| 47 | People |
Carney, Steve |
2003 |
21 |
p. 967- 1 p. |
artikel |
||
| 48 | People |
Owens, Joanna |
2002 |
21 |
p. 1075- 1 p. |
artikel |
||
| 49 | People |
Lawrence, Rebecca N |
2001 |
21 |
p. 1088- 1 p. |
artikel |
||
| 50 | Pharmaceuticals, biotechnology and the media |
Cookson, Clive |
2001 |
21 |
p. 1089-1091 3 p. |
artikel |
||
| 51 | Pharmaceuticals: Classes, Therapeutic Agents, Areas of ApplicationVolume 3 |
Meade, Susie J |
2001 |
21 |
p. 1099-1100 2 p. |
artikel |
||
| 52 | Pharmaceuticals: Classes, Therapeutic Agents, Areas of ApplicationVolume 1 |
Netzer, Rainer |
2001 |
21 |
p. 1098- 1 p. |
artikel |
||
| 53 | Pharmaceuticals: Classes, Therapeutic Agents, Areas of Application Volume 2 |
Alexander, Stephen |
2001 |
21 |
p. 1098-1099 2 p. |
artikel |
||
| 54 | Pharmaceuticals: Classes, Therapeutic Agents, Areas of Application Volume 4 |
Drews, Jürgen |
2001 |
21 |
p. 1100- 1 p. |
artikel |
||
| 55 | Pharmacogenomics: The Search for Individualized Therapies |
Norton, Ronald |
2002 |
21 |
p. 1085- 1 p. |
artikel |
||
| 56 | Pharmacokinetic and pharmacodynamic considerations in gene therapy |
Kamiya, Hiroyuki |
2003 |
21 |
p. 990-996 7 p. |
artikel |
||
| 57 | Pills and pumps: the future of insulin therapies |
Weidner, JohnJ. |
2001 |
21 |
p. 1093- 1 p. |
artikel |
||
| 58 | Placebos, psychotherapy and product perception – all in the mind? |
Rowe, Raymond C. |
2001 |
21 |
p. 1075-1076 2 p. |
artikel |
||
| 59 | Population-based gene discovery in the post-genomic era |
Zak, Naomi B |
2001 |
21 |
p. 1111-1115 5 p. |
artikel |
||
| 60 | Quality: an old solution to new discovery dilemmas? |
Volsen, Stephen G. |
2004 |
21 |
p. 903-905 3 p. |
artikel |
||
| 61 | Raising funding for early stage start-up companies |
Whitehead, George |
2002 |
21 |
p. 1076-1079 4 p. |
artikel |
||
| 62 | Rapid molecular theranostics in infectious diseases |
Picard, François J |
2002 |
21 |
p. 1092-1101 10 p. |
artikel |
||
| 63 | Scaling the Ladder |
Rowe, Raymond C. |
2005 |
21 |
p. 1419-1420 2 p. |
artikel |
||
| 64 | Specific enzyme identified that snips APP into β-amyloid |
Senior, Kathryn |
2005 |
21 |
p. 1408- 1 p. |
artikel |
||
| 65 | Stapled peptide induces cancer cell death |
Whelan, Jo |
2004 |
21 |
p. 907- 1 p. |
artikel |
||
| 66 | Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development |
Carney, Steve |
2005 |
21 |
p. 1411-1414 4 p. |
artikel |
||
| 67 | Strategies for designing clinical trials for oligonucleotide therapeutics |
Wacheck, Volker |
2004 |
21 |
p. 918-923 6 p. |
artikel |
||
| 68 | Sulforaphane halts breast cancer cell growth |
Johnston, Nicole |
2004 |
21 |
p. 908- 1 p. |
artikel |
||
| 69 | Targeting JNK3 for the treatment of neurodegenerative disorders |
Resnick, Lynn |
2004 |
21 |
p. 932-939 8 p. |
artikel |
||
| 70 | Targeting the extracellular matrix to stop tumour progression |
Habeck, Martina |
2001 |
21 |
p. 1077-1078 2 p. |
artikel |
||
| 71 | Tea: a rich brew of anti-cancer magic bullets? |
Senior, Kathryn |
2001 |
21 |
p. 1079-1080 2 p. |
artikel |
||
| 72 | The impact of informatics and computational chemistry on synthesis and screening |
Manly, Charles J |
2001 |
21 |
p. 1101-1110 10 p. |
artikel |
||
| 73 | The lost science of formulation |
Brown, Marc B. |
2005 |
21 |
p. 1405-1407 3 p. |
artikel |
||
| 74 | The role of nanobiotechnology in drug discovery |
Jain, Kewal K. |
2005 |
21 |
p. 1435-1442 8 p. |
artikel |
||
| 75 | Topological proteomics: a new approach to drug discovery |
Owens, Joanna |
2001 |
21 |
p. 1081-1082 2 p. |
artikel |
||
| 76 | Trends in genomic variation: a view of some of the latest technologies |
Ritchie, Marylyn D. |
2005 |
21 |
p. 1417-1418 2 p. |
artikel |
||
| 77 | Use of human tissue in ADME and safety profiling of development candidates |
Coleman, Robert A |
2001 |
21 |
p. 1116-1126 11 p. |
artikel |
||
| 78 | Vaccine discovery research by reverse engineering |
Zagursky, Robert |
2003 |
21 |
p. 972-973 2 p. |
artikel |
||
| 79 | Widening opportunities in restenosis |
McDonnell, Sean |
2005 |
21 |
p. 1415-1417 3 p. |
artikel |
||
| 80 | Zebularine: a candidate for epigenetic cancer therapy |
Bradbury, Jane |
2004 |
21 |
p. 906-907 2 p. |
artikel |
80 gevonden resultaten